11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6360/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :21/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "TUMOUR VACCINE COMPRISING ALLOGENEIC OR XENOGENEIC TUMOUR CELLS"<br />

(51) International classification :A61K 39/00 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :0601598.6<br />

1)STATHOPOULOS, APOSTOLOS<br />

(32) Priority Date :26/01/2006<br />

Address <strong>of</strong> Applicant :17 RUE BELLE-VUE, L-4974<br />

(33) Name <strong>of</strong> priority country :U.K.<br />

DIPPACH, LUXEMBOURG, BELGIUM Belgium<br />

(86) International Application No :PCT/EP2007/050807 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:26/01/2007<br />

1)STATHOPOULOS, APOSTOLOS<br />

(87) International Publication No :WO 2007/085648<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention provides a composition for the treatment <strong>of</strong> a tumour, comprising: (i) allogeneic or xenogeneic tumour cells;<br />

<strong>and</strong> (ii) a pharmaceutically acceptable excipient. If two or more heterozygous individuals have the same cancer/tumour <strong>of</strong> the same or<br />

similar histological grade, then transplantation <strong>of</strong> tumour/cancer tissue/cells <strong>from</strong> one individual to another will not only induce<br />

rejection <strong>of</strong> the transplanted tissue/cancer, but will also increase the immunological awareness <strong>of</strong> the immune system to peptides<br />

shared between the tumours/cancers <strong>and</strong> other tumours possessing similar peptides.<br />

No. <strong>of</strong> Pages : 27 No. <strong>of</strong> Claims : 13<br />

The Patent Office Journal 24/10/2008 25845

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!